Yanlv Ren

683 total citations
13 papers, 532 citations indexed

About

Yanlv Ren is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Yanlv Ren has authored 13 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Yanlv Ren's work include Cancer and Skin Lesions (3 papers), Epigenetics and DNA Methylation (3 papers) and Cancer-related molecular mechanisms research (3 papers). Yanlv Ren is often cited by papers focused on Cancer and Skin Lesions (3 papers), Epigenetics and DNA Methylation (3 papers) and Cancer-related molecular mechanisms research (3 papers). Yanlv Ren collaborates with scholars based in China and United States. Yanlv Ren's co-authors include Da Pang, Zhigao Li, Jinsong Wang, Yingqiang Fu, Ming Zhang, Ning Wang, Peng Song, Yanni Song, Shanshan Sun and Cheng Qian and has published in prestigious journals such as PLoS ONE, Cell Death and Disease and Oncotarget.

In The Last Decade

Yanlv Ren

13 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yanlv Ren China	11	305	296	145	112	101	13	532
Paul Thiruchelvam United Kingdom	12	315 1.0×	361 1.2×	84 0.6×	197 1.8×	18 0.2×	22	649
Samuel F. Gilbert United States	9	161 0.5×	250 0.8×	124 0.9×	106 0.9×	16 0.2×	14	436
Tadeusz Dębniak Poland	13	265 0.9×	189 0.6×	175 1.2×	151 1.3×	20 0.2×	18	580
Pontus Berglund Sweden	9	171 0.6×	71 0.2×	37 0.3×	148 1.3×	73 0.7×	15	414
Jiehua He China	10	151 0.5×	157 0.5×	59 0.4×	120 1.1×	14 0.1×	18	353
Piera Gargiulo Italy	10	97 0.3×	101 0.3×	57 0.4×	204 1.8×	19 0.2×	26	393
Raquel Ramírez‐Moreno Spain	12	170 0.6×	209 0.7×	129 0.9×	225 2.0×	8 0.1×	23	499
Ritu Roydasgupta United States	7	181 0.6×	109 0.4×	131 0.9×	119 1.1×	20 0.2×	11	372
M Rath Germany	8	262 0.9×	302 1.0×	65 0.4×	142 1.3×	12 0.1×	13	442
Seden Küçücük Türkiye	11	103 0.3×	116 0.4×	61 0.4×	131 1.2×	22 0.2×	32	322

Countries citing papers authored by Yanlv Ren

Since Specialization

Citations

This map shows the geographic impact of Yanlv Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanlv Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanlv Ren more than expected).

Fields of papers citing papers by Yanlv Ren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanlv Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanlv Ren. The network helps show where Yanlv Ren may publish in the future.

Co-authorship network of co-authors of Yanlv Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Yanlv Ren. A scholar is included among the top collaborators of Yanlv Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanlv Ren. Yanlv Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Liu, Wei, et al.. (2024). Unveiling heterogeneity and prognostic markers in ductal breast cancer through single-cell RNA-seq. Cancer Cell International. 24(1). 266–266. 5 indexed citations

Li, Xin, Zehao Li, Lin Li, et al.. (2023). Toremifene, an Alternative Adjuvant Endocrine Therapy, Is Better Than Tamoxifen in Breast Cancer Patients with CYP2D6*10 Mutant Genotypes. Cancer Research and Treatment. 56(1). 134–142. 4 indexed citations

Zhang, Ming, Ning Wang, Peng Song, et al.. (2020). LncRNA GATA3‐AS1 facilitates tumour progression and immune escape in triple‐negative breast cancer through destabilization of GATA3 but stabilization of PD‐L1. Cell Proliferation. 53(9). e12855–e12855. 123 indexed citations

Wang, Hongbin, Yanlv Ren, Cheng Qian, et al.. (2020). Over-expression of CDX2 alleviates breast cancer by up-regulating microRNA let-7b and inhibiting COL11A1 expression. Cancer Cell International. 20(1). 13–13. 17 indexed citations

Yan, Meisi, Jinsong Wang, Yanlv Ren, et al.. (2019). Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization. Cell Death and Disease. 10(3). 204–204. 20 indexed citations

Ma, Fei, Wenjie Li, Chunxiao Liu, et al.. (2017). MiR-23a promotes TGF-β1-induced EMT and tumor metastasis in breast cancer cells by directly targeting CDH1 and activating Wnt/β-catenin signaling. Oncotarget. 8(41). 69538–69550. 93 indexed citations

Jiang, Yongdong, Shanshan Sun, Wei Wei, et al.. (2015). Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province. Oncotarget. 6(32). 34023–34029. 22 indexed citations

Shan, Ming, Ji Wang, Tong Liu, et al.. (2015). HOXD13 methylation status is a prognostic indicator in breast cancer.. PubMed. 8(9). 10716–24. 16 indexed citations

Song, Yanni, Xiaolong Liu, Guoqiang Zhang, et al.. (2013). Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators. World Journal of Surgical Oncology. 11(1). 129–129. 111 indexed citations

10.

Song, Yanni, Yan‐Bo Wang, Rui Huang, et al.. (2013). Surgical Treatment of Gynecomastia. Annals of Plastic Surgery. 73(3). 275–278. 11 indexed citations

11.

Zhang, Xianyu, Qian Sun, Ming Shan, et al.. (2013). Promoter Hypermethylation of ARID1A Gene Is Responsible for Its Low mRNA Expression in Many Invasive Breast Cancers. PLoS ONE. 8(1). e53931–e53931. 49 indexed citations

12.

Xu, Shouping, Yumei Yang, Weiyang Tao, et al.. (2012). Tamoxifen adherence and its relationship to mortality in 116 men with breast cancer. Breast Cancer Research and Treatment. 136(2). 495–502. 46 indexed citations

13.

Song, Yanni, Jingshu Geng, Tong Liu, et al.. (2012). Long CAG Repeat Sequence and Protein Expression of Androgen Receptor Considered as Prognostic Indicators in Male Breast Carcinoma. PLoS ONE. 7(12). e52271–e52271. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact